Each forward-looking statement speaks only as of the date of the particular statement. Many of our customers are invoiced on an annual basis. Competition & The eValuator product has little direct competition. There will be larger and more sophisticated competitors than our Company. Strategic alliances between vendors of other healthcare systems are increasing. This could adversely affect the market price of our securities. & 13 & & Our SaaS and support services could experience interruptions. & These modifications commenced with the month ending June 30, 2020. & Most of these factors are beyond our control. As of January 31, 2021, we had no shares of preferred stock outstanding. & However, they are not the only ones facing the Company. We continue to make decisions supporting our focus in the middle of the revenue cycle. This is a notable change to existing processes of our customers. The Company did not incur any rationalization charges in fiscal year 2020. & We also provide a reconciliation of non-GAAP to GAAP measures used. The term loan balance as of January 31, 2021 is the Company’s PPP loan. 44 & & STREAMLINE HEALTH SOLUTIONS, INC. Property and Equipment & Property and equipment are stated at cost. There were no changes to the fair value methods. Revenue is recognized at a point in time. Audit services are a separate performance obligation. We recognize revenue over time as the services are performed. & Payments from customers have been received within normal time frames for the industry. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The standard became effective for us on February 1, 2020. The lease terminates on March 31, 2023. The Company used a discount rate of 8% to determine the lease liability. The agreement initially required the Company to maintain a minimum Asset Coverage Ratio. The PPP loan carries an interest rate of 1.0% per annum. However, under certain criteria, the loan may be forgiven. The TCJA also eliminated the ability to carryback net operating losses. 180 Consulting has registration rights on all issued securities. During fiscal 2020, the Company paid fees to 180 Consulting totalling $580,000. The MSA includes a termination clause upon a 90-day written notice. The price to the public in the Offering was $1.60 per share of common stock. The following description is a summary and does not purport to be complete. Holders of our Common Stock do not have cumulative voting rights. & EX-32.2 8 ex32-2.htm & Exhibit 32.2 & STREAMLINE HEALTH SOLUTIONS, INC. & Cash deposits may exceed FDIC insured levels from time
to time. Further, the forfeiture rate impacts the
amount of aggregate compensation.